<br>COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever</br><em> – by Manica Balasegaram</em>

COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever – by Manica Balasegaram

2 April 2020
<br>The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation</br><em> – by Ryan Cirz and Kevin Krause</em>

The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation – by Ryan Cirz and Kevin Krause

17 March 2020
<br>Diagnostics to safeguard new and current antibiotics for gonorrhoea</br><em> – by Cassandra Kelly-Cirino and Cecilia Ferreyra</em>

Diagnostics to safeguard new and current antibiotics for gonorrhoea – by Cassandra Kelly-Cirino and Cecilia Ferreyra

22 January 2020
<br>On fireworks and finding ways to address drug-resistance in low- and middle-income countries</br><em> – by Ramanan Laxminarayan</em>

On fireworks and finding ways to address drug-resistance in low- and middle-income countries – by Ramanan Laxminarayan

16 December 2019
<br>Bringing antimicrobial research and development to Africa – the time is now</br><em> – by Greg Basarab and Kelly Chibale</em>

Bringing antimicrobial research and development to Africa – the time is now – by Greg Basarab and Kelly Chibale

3 December 2019
<br>Talking about the ‘antibiotic apocalypse’ won’t encourage public action – here’s why</br><em> – by Tim Jinks</em>

Talking about the ‘antibiotic apocalypse’ won’t encourage public action – here’s why – by Tim Jinks

19 November 2019
<br>A new cephalosporin has been approved</br><em> – by Ursula Theuretzbacher</em>

A new cephalosporin has been approved – by Ursula Theuretzbacher

15 November 2019
<br>Are new antibiotic combinations the solution to the AMR crisis?</br><em> – by Anthony Coates</em>

Are new antibiotic combinations the solution to the AMR crisis? – by Anthony Coates

15 October 2019
<br>Lessons from a recent outbreak of carbapenem-resistant <em>Klebsiella pneumoniae</em> in a neonatal unit</br><em> – by Adrie Bekker</em>

Lessons from a recent outbreak of carbapenem-resistant Klebsiella pneumoniae in a neonatal unit – by Adrie Bekker

23 September 2019
<br>Journey towards a better antimicrobial pipeline; is there light at the end of the tunnel?</br><em> – by Colm Leonard & Tracy Parker</em>

Journey towards a better antimicrobial pipeline; is there light at the end of the tunnel? – by Colm Leonard & Tracy Parker

2 September 2019
<br>Addressing Gram-negative permeation & efflux evasion with a collaborative discovery tool</br><em> – by Wes Kim & Katie Prosen</em>

Addressing Gram-negative permeation & efflux evasion with a collaborative discovery tool – by Wes Kim & Katie Prosen

27 June 2019
<br>How to steward new antibiotics into low- and middle-income countries (LMICs)?</br><em> – by Marc Mendelson & Adrian Brink</em>

How to steward new antibiotics into low- and middle-income countries (LMICs)? – by Marc Mendelson & Adrian Brink

27 March 2019